Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PRIOBONE

Financiado

Cerrado

A 3D-printable biomimetic bone regeneration material

Critical-size bone defects do not heal spontaneously over the patient’s lifetime and cause substantial individual, societal and economic burden. Current treatment options are hampered by associated complications, poor functional o... ver más

30/06/2025

LUH

Presupuesto desconocido

Líder del proyecto

GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOV... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-01

ERC-2023-POC: ERC PROOF OF CONCEPT GRANTS Objective:Objectives:The ERC Proof of Concept Grants aim at facilitating exploration of the commerci...

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

LUH

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PersonalBone Multifunctional Personalized Self Assembled Biomaterials for... 1M€ Cerrado

PTQ2023-013086 Bioimpresión 3D de sustitutos óseos personalizados para la r... 92K€ Cerrado

VASCUBONE Construction kit for tailor made vascularized boneimplants 16M€ Cerrado

3D-JOINT 3D Bioprinting of JOINT Replacements 2M€ Cerrado

ImmunoBioInks Instructing Immune System to Regenerate Musculoskeletal Tiss... 191K€ Cerrado

BioForceInk Bioactive reinforcing bioink for hybrid bioprinting of impla... Cerrado

Duración del proyecto: 17 meses Fecha Inicio: 2024-01-01
Fecha Fin: 2025-06-30

Líder del proyecto

GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOV... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Critical-size bone defects do not heal spontaneously over the patient’s lifetime and cause substantial individual, societal and economic burden. Current treatment options are hampered by associated complications, poor functional or aesthetic outcomes, a limited availability of tissue for bone grafts, and high financial costs. Worldwide, more than 4 million surgeries per year require bone grafts or substitute materials. Consequently, there is a significant clinical and economic need for novel treatments for critical-size bone defects. In PRIOBONE, we propose the validation and steps towards exploitation of our newly developed, bone-mimetic 3D-printable material for bone repair. Our PRIOBONE material has the potential to outperform current treatments and alternative solutions on the market due to its biomimetic composition, excellent cytocompatibility, osteoinductive capacity, ideal mechanical properties, and its 3D printability into any desired shape. This allows us to create implants optimized for clinical and individual patient needs. This includes, e.g., the possibility to print the material into foldable and deployable 3D designs that allow a minimally invasive insertion of the material into defect sites, where it can re-expand. The use of well-established components and our “materials-only” approach will enable a faster track to clinical application and regulatory approval in comparison to approaches containing biologicals such as cells or previously unknown components. In PRIOBONE, we will validate our material for bone regeneration, undertake a comprehensive market analysis, explore target leads and transfer pathways, and elaborate our IP strategy towards commercialization. Following successful validation, we expect that PRIOBONE will provide a cost-efficient, individualizable alternative to current treatments with the potential to significantly lower the economic, individual and social burden of critical-size bone defects.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores